Using Mindfulness-Based Cognitive Therapy to Prevent Suicide Among High Suicide–Risk Patients Who Also Misuse Opioids: a Preliminary Probe of Feasibility and Effectiveness.
Knowledge of how to effectively prevent suicide attempt (SA) in high suicide–risk patients who also misuse opioids is limited. In a subset of data from 36 participants with baseline opioid misuse in a randomized clinical trial testing adjunctive mindfulness-based cognitive therapy to prevent suicide...
| Publicado en: | International Journal of Mental Health & Addiction Vol. 21; no. 6; pp. 3721 - 3735 |
|---|---|
| Autores principales: | , , , , , , , , , , , , |
| Formato: | Artículo |
| Publicado: |
Springer Nature
Dec2023
|
| Materias: | |
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ssf&AN=173850433&site=ehost-live header: @attributes: shortDbName: ssf uiTerm: 173850433 longDbName: Social Sciences Full Text (H.W. Wilson) uiTag: AN controlInfo: bkinfo: jinfo: jid: 15571874 46AW jtl: International Journal of Mental Health & Addiction issn: 15571874 maglogo: N pubinfo: dt: Dec2023 vid: 21 iid: 6 pid: 237 pub: Springer Nature artinfo: ui: 173850433 10.1007/s11469-022-00817-x ppf: 3721 ppct: 14 formats: fmt: – @attributes: type: T – @attributes: type: P size: 759KB tig: atl: Using Mindfulness-Based Cognitive Therapy to Prevent Suicide Among High Suicide–Risk Patients Who Also Misuse Opioids: a Preliminary Probe of Feasibility and Effectiveness. aug: au: Chesin, Megan S. Dave, Chintan V. Myers, Catherine Stanley, Barbara Kline, Anna Monahan, Maureen Latorre, Miriam Hill, Lauren M. St. Miller, Rachael B. King, Arlene R. Boschulte, Dianna R. Sedita, Megan Interian, Alejandro affil: https://ror.org/00k3ayt93 Department of Psychology, William Paterson University, 300 Pompton Road, 07046, Wayne, NJ, USA https://ror.org/05vt9qd57 Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers, The State University of New Jersey, New Brunswick, NJ, USA https://ror.org/003g0xf19 Department of Veterans Affairs, VA New Jersey Health Care System, East Orange, NJ, USA https://ror.org/05vt9qd57 Department of Pharmacology, Physiology, and Neuroscience, New Jersey Medical School, The State University of New Jersey, Rutgers, Newark, USA https://ror.org/04aqjf708 Department of Psychiatry, Columbia University College of Physicians and Surgeons and New York State Psychiatric Institute, New York, NY, USA https://ror.org/05vt9qd57 Department of Psychiatry, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, NJ, USA su: Suicide Mindfulness-based cognitive therapy Opioid abuse Attempted suicide Psychiatric hospital care sug: subj: Suicide Psychiatric and Substance Abuse Hospitals Residential Mental Health and Substance Abuse Facilities Mindfulness-based cognitive therapy Opioid abuse Attempted suicide Psychiatric hospital care keyword: High suicide–risk patients Mindfulness-based cognitive therapy to prevent suicide Opioid misuse Veterans High suicide–risk patients Mindfulness-based cognitive therapy to prevent suicide Opioid misuse Veterans ab: Knowledge of how to effectively prevent suicide attempt (SA) in high suicide–risk patients who also misuse opioids is limited. In a subset of data from 36 participants with baseline opioid misuse in a randomized clinical trial testing adjunctive mindfulness-based cognitive therapy to prevent suicide among high suicide–risk veterans (n = 18 per treatment condition), MBCT-S reduced the likelihood of SA and acute psychiatric hospitalization over 12-month follow-up. Those in MBCT-S had a relative risk of 17% and 42% for SA and hospitalization (p =.09,.02), respectively, compared to those receiving enhanced treatment as usual (eTAU) alone. Rates of opioid misuse during follow-up were more than halved with the addition of MBCT-S to eTAU (p =.08). Meanwhile, among trial participants who did not misuse opioids (n = 104), RRs of 64% and 77% for SA and hospitalization (p =.28,.33), respectively, were found with MBCT-S compared to eTAU. An MBCT-S trial with greater power is warranted in this population. pubtype: Academic Journal doctype: Article src: R language: English refInfo: copyright: @attributes: flag: N holdings: @attributes: islocal: N |
|---|